The complete clearance of primary AML from all organs occurred despite no significant difference in the percentage or absolute numbers of CD4+ and CD8+ T cells in the bone marrow, spleen, and blood of human AML engrafted mice treated with T564 as compared with untreated mice (Fig 6C–6F). Here, CD8A is linked to acute myeloid leukemia.